Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

Health technology assessment: the process in Brazil.

Lessa F, Ferraz MB.

Rev Panam Salud Publica. 2017 Jun 8;41:e25.

2.

Willingness to Pay in Caregivers of Patients Affected by Schizophrenia.

Daltio CS, Attux C, Ferraz MB.

J Ment Health Policy Econ. 2017 Mar 1;20(1):3-10.

PMID:
28418833
3.

Pharmacoeconomics, Outcomes Research, Health Technology Assessment, Comparative Effectiveness, Patient Centered Outcomes Research in Latin America 2016: brief update.

Augustovski F, Caro J, Ferraz MB, Zárate V.

Value Health Reg Issues. 2016 Dec;11:74-75. doi: 10.1016/j.vhri.2016.11.001. Epub 2016 Nov 23. No abstract available.

PMID:
27986202
4.

Perception of the value of generic drugs in São Paulo, Brazil.

Nardi EP, Ferraz MB.

Cad Saude Publica. 2016 Feb;32(2):e00038715. doi: 10.1590/0102-311X00038715. Epub 2016 Mar 4.

5.

Knowledge in schizophrenia: The Portuguese version of KAST (Knowledge About Schizophrenia Test) and analysis of social-demographic and clinical factors' influence.

Daltio CS, Attux C, Ferraz MB.

Schizophr Res. 2015 Oct;168(1-2):168-73. doi: 10.1016/j.schres.2015.07.009. Epub 2015 Jul 15.

PMID:
26189074
6.

Evaluation of functional capacity in individuals with signs and symptoms of musculoskeletal disease: results of the BRAZCO population study (Brazilian COPCORD Study).

Jennings F, Sato EI, da Rocha Castelar Pinheiro G, Ferraz MB.

Rheumatol Int. 2015 Nov;35(11):1873-9. doi: 10.1007/s00296-015-3299-9. Epub 2015 Jun 9.

PMID:
26055534
7.

Prevalence of musculoskeletal symptoms in the five urban regions of Brazil-the Brazilian COPCORD study (BRAZCO).

Dos Reis-Neto ET, Ferraz MB, Kowalski SC, Pinheiro Gda R, Sato EI.

Clin Rheumatol. 2016 May;35(5):1217-23. doi: 10.1007/s10067-015-2963-5. Epub 2015 May 12.

PMID:
25963999
8.

Health care: the challenge to deal with uncertainty and value judgment.

Ferraz MB.

Cost Eff Resour Alloc. 2015 May 1;13:8. doi: 10.1186/s12962-015-0035-y. eCollection 2015.

9.

Brazilian urban population norms derived from the health-related quality of life SF-6D.

Ciconelli RM, Ferraz MB, Kowalski S, Pinheiro Gda R, Sato EI.

Qual Life Res. 2015 Oct;24(10):2559-64. doi: 10.1007/s11136-015-0991-x. Epub 2015 Apr 18.

PMID:
25894065
10.

Perceptions of the population regarding generic drugs in Brazil: a nationwide survey.

Nardi EP, Ferraz MB, Pinheiro GR, Kowalski SC, Sato EI.

BMC Public Health. 2015 Feb 10;15:117. doi: 10.1186/s12889-015-1475-1.

11.

Health economics, equity, and efficiency: are we almost there?

Ferraz MB.

Clinicoecon Outcomes Res. 2015 Feb 12;7:119-22. doi: 10.2147/CEOR.S78093. eCollection 2015.

12.

[Monitoring the functional capacity of patients with rheumatoid arthritis for three years].

de Oliveira LM, Natour J, Roizenblatt S, de Araujo PM, Ferraz MB.

Rev Bras Reumatol. 2015 Jan-Feb;55(1):62-7. doi: 10.1016/j.rbr.2014.06.007. Epub 2014 Oct 6. Portuguese.

13.

The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil.

Borges NB, Ferraz MB, Chacra AR.

Diabetol Metab Syndr. 2014 Nov 8;6(1):122. doi: 10.1186/1758-5996-6-122. eCollection 2014.

14.

Quality-adjusted life-years gain and health status in patients with OSAS after one year of continuous positive airway pressure use.

Rizzi CF, Ferraz MB, Poyares D, Tufik S.

Sleep. 2014 Dec 1;37(12):1963-8. doi: 10.5665/sleep.4250.

15.
16.

Characterization of knee osteoarthritis in Latin America. A comparative analysis of clinical and health care utilization in Argentina, Brazil, and Mexico.

Burgos-Vargas R, Cardiel MH, Loyola-Sánchez A, De Abreu MM, Pons-Estel BA, Rossignol M, Avouac B, Ferraz MB, Halhol H.

Reumatol Clin. 2014 May-Jun;10(3):152-9. doi: 10.1016/j.reuma.2013.07.013. Epub 2013 Nov 26.

17.

The cost of type 1 diabetes: a nationwide multicentre study in Brazil.

Cobas RA, Ferraz MB, Matheus AS, Tannus LR, Negrato CA, Antonio de Araujo L, Dib SA, Gomes MB; Brazilian Type 1 Diabetes Study Group.

Bull World Health Organ. 2013 Jun 1;91(6):434-40. doi: 10.2471/BLT.12.110387. Epub 2013 Apr 4.

18.

A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil.

de Abreu MM, Walker DR, Sesso RC, Ferraz MB.

Perit Dial Int. 2013 May-Jun;33(3):304-15. doi: 10.3747/pdi.2011.00138. Epub 2012 Dec 3.

19.

Evaluation of quality of life in severely obese patients after bariatric surgery carried out in the public healthcare system.

Khawali C, Ferraz MB, Zanella MT, Ferreira SR.

Arq Bras Endocrinol Metabol. 2012 Feb;56(1):33-8.

20.

Willingness to pay as patient preference to bariatric surgery.

Khawali C, Ferraz MB, Zanella MT, Ferreira SR.

Health Expect. 2014 Feb;17(1):73-81. doi: 10.1111/j.1369-7625.2011.00738.x. Epub 2011 Nov 10.

Supplemental Content

Loading ...
Support Center